Supernus Pharmaceuticals Statistics
Total Valuation
SUPN has a market cap or net worth of $1.96 billion. The enterprise value is $1.59 billion.
| Market Cap | 1.96B |
| Enterprise Value | 1.59B |
Important Dates
The last earnings date was Monday, November 4, 2024, after market close.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SUPN has 55.22 million shares outstanding. The number of shares has decreased by -2.68% in one year.
| Current Share Class | 55.22M |
| Shares Outstanding | 55.22M |
| Shares Change (YoY) | -2.68% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 4.24% |
| Owned by Institutions (%) | 101.30% |
| Float | 47.76M |
Valuation Ratios
The trailing PE ratio is 33.12 and the forward PE ratio is 19.26.
| PE Ratio | 33.12 |
| Forward PE | 19.26 |
| PS Ratio | 2.98 |
| Forward PS | 3.17 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 5.59 |
| P/FCF Ratio | 11.37 |
| P/OCF Ratio | 11.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.05, with an EV/FCF ratio of 9.25.
| EV / Earnings | 26.65 |
| EV / Sales | 2.44 |
| EV / EBITDA | 11.05 |
| EV / EBIT | 26.18 |
| EV / FCF | 9.25 |
Financial Position
The company has a current ratio of 2.20, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.20 |
| Quick Ratio | 1.88 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.24 |
| Debt / FCF | 0.22 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.22% and return on invested capital (ROIC) is 3.80%.
| Return on Equity (ROE) | 6.22% |
| Return on Assets (ROA) | 2.89% |
| Return on Capital (ROIC) | 3.80% |
| Revenue Per Employee | $999,957 |
| Profits Per Employee | $91,583 |
| Employee Count | 652 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 0.97 |
Taxes
In the past 12 months, SUPN has paid $12.77 million in taxes.
| Income Tax | 12.77M |
| Effective Tax Rate | 17.61% |
Stock Price Statistics
The stock price has increased by +26.04% in the last 52 weeks. The beta is 0.90, so SUPN's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +26.04% |
| 50-Day Moving Average | 35.58 |
| 200-Day Moving Average | 31.82 |
| Relative Strength Index (RSI) | 43.56 |
| Average Volume (20 Days) | 348,601 |
Short Selling Information
The latest short interest is 6.45 million, so 11.69% of the outstanding shares have been sold short.
| Short Interest | 6.45M |
| Short Previous Month | 6.52M |
| Short % of Shares Out | 11.69% |
| Short % of Float | 13.51% |
| Short Ratio (days to cover) | 15.73 |
Income Statement
In the last 12 months, SUPN had revenue of $651.97 million and earned $59.71 million in profits. Earnings per share was $1.07.
| Revenue | 651.97M |
| Gross Profit | 580.54M |
| Operating Income | 60.78M |
| Pretax Income | 37.42M |
| Net Income | 59.71M |
| EBITDA | 144.03M |
| EBIT | 60.78M |
| Earnings Per Share (EPS) | $1.07 |
Balance Sheet
The company has $403.21 million in cash and $38.15 million in debt, giving a net cash position of $365.06 million or $6.61 per share.
| Cash & Cash Equivalents | 403.21M |
| Total Debt | 38.15M |
| Net Cash | 365.06M |
| Net Cash Per Share | $6.61 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 18.24 |
| Working Capital | 348.50M |
Cash Flow
In the last 12 months, operating cash flow was $172.50 million and capital expenditures -$476,000, giving a free cash flow of $172.03 million.
| Operating Cash Flow | 172.50M |
| Capital Expenditures | -476,000 |
| Free Cash Flow | 172.03M |
| FCF Per Share | $3.12 |
Margins
Gross margin is 89.04%, with operating and profit margins of 9.32% and 9.16%.
| Gross Margin | 89.04% |
| Operating Margin | 9.32% |
| Pretax Margin | 11.12% |
| Profit Margin | 9.16% |
| EBITDA Margin | 22.09% |
| EBIT Margin | 9.32% |
| FCF Margin | 26.39% |
Dividends & Yields
SUPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.68% |
| Shareholder Yield | 2.68% |
| Earnings Yield | 3.05% |
| FCF Yield | 8.79% |
Analyst Forecast
The average price target for SUPN is $36.00, which is 1.61% higher than the current price. The consensus rating is "Hold".
| Price Target | $36.00 |
| Price Target Difference | 1.61% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 6.21% |
| EPS Growth Forecast (5Y) | 151.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUPN has an Altman Z-Score of 4.37 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.37 |
| Piotroski F-Score | 7 |